Novoprotein Scientific Inc.

688137

CNE100005NZ4

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
35.92 ^CNY	+1.76%		+0.62%	-35.26%

04-28	Novoprotein Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-23	Novoprotein Scientific Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Novoprotein Scientific Inc.(SHSE:688137) added to Shanghai Stock Exchange A Share Index

October 04, 2023 at 12:00 am

Novoprotein Scientific Inc Added to Shanghai Stock Exchange A Share Index

Latest news about Novoprotein Scientific Inc.

Novoprotein Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
Novoprotein Scientific Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Novoprotein Scientific Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Novoprotein Scientific Inc.(SHSE:688137) added to Shanghai Stock Exchange Composite Index	23-10-04	CI
Novoprotein Scientific Inc.(SHSE:688137) added to Shanghai Stock Exchange A Share Index	23-10-04	CI
Certain A Shares of Novoprotein Scientific Inc. are subject to a Lock-Up Agreement Ending on 23-SEP-2023.	23-09-22	CI
Novoprotein Scientific Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Suzhou Novoprotein Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Suzhou Novoprotein Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Suzhou Novoprotein Scientific Co., Ltd. has completed an IPO in the amount of CNY 1.862982 billion.	22-09-22	CI

Chart Novoprotein Scientific Inc.

Duration

Period

More charts

Novoprotein Scientific Inc is a China-based company mainly engaged in the provision of recombinant protein application solutions. The Company is mainly engaged in the research and development, production and sales of target and factor proteins, recombinant antibodies, enzymes and reagents, and the provision of related technical services. The Company's main products include novel coronavirus diagnostic antibodies, novel coronavirus diagnostic antigens, novel coronavirus pseudoviruses, novel coronavirus non-structural proteins and messenger ribonucleic acid (mRNA) raw materials enzymes and reagents. Its products and services are mainly used in biological medicine, basic research of life science, in vitro diagnosis, mRNA vaccine drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
NOVOPROTEIN SCIENTIFIC INC.	-35.26%	342M
CSL LIMITED	-2.29%	89.38B
SAMSUNG BIOLOGICS CO.,LTD.	-3.95%	37.92B
BIOGEN INC.	-13.07%	32.04B
UCB	+63.05%	26.03B
BIOMARIN PHARMACEUTICAL INC.	-22.14%	14.14B
INCYTE CORPORATION	-7.96%	12.88B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.33%	11.77B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-46.33%	10.85B
SWEDISH ORPHAN BIOVITRUM AB	+5.77%	8.92B